Jiayu Wang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Autism Spectrum Disorder

Ejection Fraction

Positive Breast Cancer

Top Venues

Journal of personalized medicine

Cancer medicine

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhijun Li, Yi-Qun Han, Jiayu Wang, Binghe Xu
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Yiqun Han, Jiayu Wang, Binghe Xu
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Zhijun Li, Yi-Qun Han, Jiayu Wang, Binghe Xu
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Yiqun Han, Jiayu Wang, Binghe Xu
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Yiqun Han, Jiayu Wang, Binghe Xu
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer. Journal of personalized medicine 13 (3) (2023)
Hangcheng Xu, Yi-Qun Han, Yun Wu, Yan Wang, Jiayu Wang, Bing-He Xu
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysis. Cancer medicine (2022)
Yun Wu, Yiqun Han, Qing Li, Pin Zhang, Peng Yuan, Yang Luo, Ying Fan, Shanshan Chen, Ruigang Cai, Qiao Li, Hangcheng Xu, Yan Wang, Fei Ma, Jiayu Wang, Binghe Xu
Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer. Breast cancer research and treatment 193 (2) (2022)
Yiqun Han, Yun Wu, Hangcheng Xu, Jiayu Wang, Bing-He Xu
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study. International journal of clinical oncology 27 (4) (2022)
Yan Wang, Hangcheng Xu, Yi-Qun Han, Yun Wu, Jiayu Wang
Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis. Cancers 14 (14) (2022)